Application Sponsors
Marketing Status
Application Products
| 001 | SPRAY, METERED;NASAL | EQ 0.125MG BASE/SPRAY | 0 | AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | 
FDA Submissions
 | ORIG | 1 | AP | 2015-07-28 |   | 
| LABELING; Labeling | SUPPL | 4 | AP | 2021-04-30 | STANDARD  | 
| LABELING; Labeling | SUPPL | 7 | AP | 2021-04-30 | STANDARD  | 
Submissions Property Types
| ORIG | 1 | Null | 42 | 
| SUPPL | 4 | Null | 7 | 
| SUPPL | 7 | Null | 15 | 
TE Codes
CDER Filings
BRECKENRIDGE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90176
            [companyName] => BRECKENRIDGE
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZELASTINE HYDROCHLORIDE","activeIngredients":"AZELASTINE HYDROCHLORIDE","strength":"EQ 0.125MG BASE\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AZELASTINE HYDROCHLORIDE","submission":"AZELASTINE HYDROCHLORIDE","actionType":"EQ 0.125MG BASE\/SPRAY","submissionClassification":"SPRAY, METERED;NASAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )
)